What is the clinical and cost effectiveness of oral, subcutaneous and intravenous diuretic therapy in the community for people with advanced heart failure and significant peripheral fluid overload?
The clinical and cost effectiveness of oral, subcutaneous and intravenous diuretic therapy in the community for people with advanced heart failure and significant peripheral fluid overload is not well established. Studies have shown that diuretic therapy may be beneficial in reducing fluid overload in some patients, but further research is needed to determine the optimal dose, route and timing of administration for different patient populations. Additionally, the long-term safety and efficacy of these therapies remain unclear.